Cargando…
Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy
BACKGROUND: In this article, we present recent evidence from studies focused on the implementation, effectiveness and cost-effectiveness of pre-exposure prophylaxis (PrEP) for HIV infection; discuss PrEP scale-up to date, including the observed levels of access and policy development; and elaborate...
Autores principales: | Cáceres, Carlos F, Borquez, Annick, Klausner, Jeffrey D, Baggaley, Rachel, Beyrer, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071779/ https://www.ncbi.nlm.nih.gov/pubmed/27760685 http://dx.doi.org/10.7448/IAS.19.7.21108 |
Ejemplares similares
-
Pre-Exposure Prophylaxis for HIV Infection as a Public Health Tool
por: Beyrer, Chris, et al.
Publicado: (2022) -
Is Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?
por: Kojima, Noah, et al.
Publicado: (2016) -
Lessons from a decade of voluntary medical male circumcision implementation and their application to HIV pre-exposure prophylaxis scale up
por: Reed, Jason B, et al.
Publicado: (2018) -
Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19
por: Stricker, Raphael B, et al.
Publicado: (2020) -
Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women
por: Fesler, Melissa C, et al.
Publicado: (2021)